Noyes R, Burrows G D, Reich J H, Judd F K, Garvey M J, Norman T R, Cook B L, Marriott P
Department of Psychiatry, University of Iowa, College of Medicine, Iowa City 52242-1000, USA.
J Clin Psychiatry. 1996 Aug;57(8):349-55.
Alprazolam has proven efficacy as a treatment for panic disorder, but the place of other benzodiazepines is less well established.
To compare the efficacy and tolerability of diazepam and alprazolam for the disorder, a placebo-controlled, double-blind trial was undertaken in two sites. Two hundred forty-one subjects with panic disorder or agoraphobia with panic attacks were randomly assigned to flexible doses of diazepam, alprazolam, or placebo for 8 weeks.
At the end of the trial, over 60% of subjects taking either diazepam or alprazolam were at least moderately improved compared with less than 30% of those taking placebo. On all measures of efficacy, subjects taking diazepam and alprazolam showed an equally favorable response. Despite some sedation early in the trial, both drugs were tolerated well. More severely ill subjects responded less well to either benzodiazepine.
The results indicate that diazepam is an effective alternative to alprazolam for the treatment of panic disorder.
阿普唑仑已被证实对惊恐障碍有效,但其他苯二氮䓬类药物的地位尚不明确。
为比较地西泮和阿普唑仑对该疾病的疗效及耐受性,在两个地点开展了一项安慰剂对照、双盲试验。241名患有惊恐障碍或伴有惊恐发作的广场恐惧症患者被随机分配接受灵活剂量的地西泮、阿普唑仑或安慰剂治疗,为期8周。
试验结束时,服用地西泮或阿普唑仑的受试者中超过60%至少有中度改善,而服用安慰剂的受试者中这一比例不到30%。在所有疗效指标上,服用地西泮和阿普唑仑的受试者反应同样良好。尽管试验初期有一些镇静作用,但两种药物耐受性均良好。病情较重的受试者对两种苯二氮䓬类药物的反应较差。
结果表明,地西泮是治疗惊恐障碍的一种有效替代阿普唑仑的药物。